Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis

Summary

This study will evaluate the safety and efficacy of mesenchymal stem cells in patients with cirrhosis of liver. Stem cells will be injected into the hepatic artery. Improvement in various parameters will be observed over 2 years.

Timeline

Start

2012-06

Primary completion

2016-04

Completion

2016-04

Drugs

Indications